Preformulation and development of chemically stable lipid emulsions containing a novel taxane derivative, TM-2

European Journal of Lipid Science and Technology

Volumn 116, Issue 4, 2014, Pages 486-496

  Shi, Jianli ^a   Chen, Xi ^a   Gu, Yuechen ^a   Hu, Xi ^a   Zhang, Ling ^a   Li, Yan ^a   Cai, Cuifang ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Degradation kinetics; Formulation; Preformulation study; Stability; TM 2 lipid emulsion

Indexed keywords

EID: 84893876804     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201300371     Document Type: Article

References (40)

1. Mugabe, C., Liggins, R., Guan, D., Manisali, I. et al., Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols. Int. J. Pharm. 2011, 404, 238-249.
2. Crown, J., O'Leary, M., The taxanes: An update. Lancet 2000, 355, 1176-1178.
3. Pazdur, R., Kudelka, A. P., Kavanagh, J. J., Cohen, P. R., Raber, M. N., The taxoids: Paclitaxel (Taxol®) and docetaxel (Taxotere®). Cancer Treat. Rev. 1993, 19, 351-386.
4. He, L., Orr, G. A., Horwitz, S. B., Novel molecules that interact with microtubules and have functional activity similar to Taxol™. Drug Discov. Today 2001, 6, 1153-1164.
5. Herbst, R. S., Khuri, F. R., Mode of action of docetaxel - a basis for combination with novel anticancer agents. Cancer Treat. Rev. 2003, 29, 407-415.
6. Murray, S., Briasoulis, E., Linardou, H., Bafaloukos, D., Papadimitriou, C., Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies. Cancer Treat. Rev. 2012, 38, 890-903.
7. Li, Y., Geng, M., Wang, J., Liu, H. et al., TM-2 China Patent 102241648 A, p. 28, 2011.
8. Mi, Y., Liu, Y., Feng, S.-S., Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials 2011, 32, 4058-4066.
9. Lee, S.-W., Yun, M.-H., Jeong, S. W., In, C.-H. et al., Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. J. Control. Release 2011, 155, 262-271.
10. Tije, A. J. T., Verweij, J., Loos, W. J., Sparreboom, A., Pharmacological effects of formulation vehicles: Implications for cancer chemotherapy. Clin. Pharm. 2003, 42, 665-685.
11. Gelderblom, H., Verweij, J., Nooter, K., Sparreboom, A., Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 2001, 37, 1590-1598.
12. Wang, Y. J., Wang, J., Zhang, H. Y., He, H. B., Tang, X., Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres. J. Pharm. Pharmacol. 2007, 59, 351-357.
13. Mizushima, Y., Lipid microspheres (lipid emulsions) as a drug carrier - an overview. Adv. Drug Deliv. Rev. 1996, 20, 113-115.
14. Yamaguchi, T., Lipid microspheres as drug carriers: A pharmaceutical point of view. Adv. Drug Deliv. Rev. 1996, 20, 117-130.
15. Benita, S., Levy, M., Submicron emulsions as colloidal drug carriers for intravenous administration: Comprehensive physicochemical characterization. Int. J. Pharm. 1993, 82, 1069-1079.
16. Wang, J., Cui, Y., Tang, X., Chemical stability of teniposide in aqueous and parenteral lipid emulsions. Drug Dev. Ind. Pharm. 2009, 35, 508-513.
17. Müller, R., Schmidt, S., Buttle, I., Akkar, A. et al., SolEmuls® - novel technology for the formulation of iv emulsions with poorly soluble drugs. Ind. J. Pharm. 2004, 269, 293-302.
18. Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S. et al., Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur. J. Pharm. Biopharm. 2005, 59, 177-187.
19. Fry, D. W., White, J. C., Goldman, I. D., Rapid separation of low molecular weight solutes from liposomes without dilution. Anal. Biochem. 1978, 90, 809-815.
20. Piper, S., Rohm, K., Boldt, J., Odermatt, B. et al., Hepatocellular integrity in patients requiring parenteral nutrition: Comparison of structured MCT/LCT vs. a standard MCT/LCT emulsion and a LCT emulsion. Eur. J. Anaesth. 2008, 25, 557.
21. Jiang, S., Wang, F., Zhu, S., Zhang, X. et al., Preformulation study of Methazolamide for topical ophthalmic delivery: Physicochemical properties and degradation kinetics in aqueous solutions. Int. J. Pharm. 2013, 448, 390-393.
22. Han, S-Y., Qiao, J-Q., Zhang, Y-Y., Lian, H-Z., Ge, X., Determination of n-octanol/water partition coefficients of weak ionizable solutes by RP-HPLC with neutral model compounds. Talanta 2012, 97, 355-361.
23. Ghebremeskel, A. N., Vemavarapu, C., Lodaya, M., Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int. J. Pharm. 2007, 328, 119-129.
24. Schaupp, K., Polzer, J., Kerbl, J., Lanthaler, K. et al., United States Patent 5496818, 1996.
25. Nakanishi, S., Tominaga, T., Yamanaka, I., Higo, T., Shibata, T., European Patent 0652751, 1996.
26. Teng, X. W., Cutler, D. C., Davies, N. M., Degradation kinetics of mometasone furoate in aqueous systems. Int. J. Pharm. 2003, 259, 129-141.
27. Che, X., Shen, L., Xu, H., Liu, K., Isolation and characterization of process-related impurities and degradation products in larotaxel. J. Pharm. Biomed. Anal. 2011, 55, 1190-1196.
28. Jumaa, M., Müller, B. W., The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm. 1998, 163, 81-89.
29. Driscoll, D. F., Bacon, M. N., Bistrian, B. R., Physicochemical stability of two types of intravenous lipid emulsion as total nutrient admixtures. J. Parenter. Enteral Nutr. 2000, 24, 15-22.
30. Li, F., Wang, T., He, H. B., Tang, X., The properties of bufadienolides-loaded nano-emulsion and submicro-emulsion during lyophilization. Int. J. Pharm. 2008, 349, 291-299.
31. Levy, M., Benita, S., Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use. Int. J. Pharm. 1989, 54, 103-112.
32. Hansrani, P. K., Studies on intravenous fat emulsions, Ph.D. Thesis, University of Nottingham. 1980.
33. Yamaguchi, T., Nishizaki, K., Itai, S., Hayashi, H., Ohshima, H., Physicochemical characterization of parenteral lipid emulsion: Determination of hamaker constants and activation energy of coalescence. Pharm. Res. 1995, 12, 342-347.
34. Strichartz, G. R., Sanchez, V., Arthur, G. R., Chafetz, R., Martiny, D., Fundamental properties of local anesthetics. II. Measured octanol buffer partition coefficients and pKa values of clinically used drugs. Anesth. Analg. 1990, 71, 158-170.
35. Benita, S., Friedman, D., Weinstock, M., Physostigmine emulsion: A new injectable controlled release delivery system. Int. J. Pharm. 1986, 30, 47-55.
36. Magalhaes, N., Cave, G., Seiller, M., Benita, S., The stability and in vitro release kinetics of a clofibride emulsion. Int. J. Pharm. 1991, 76, 225-237.
37. Chaturvedi, P., Patel, N., Lodhi, S., Effect of terminal heat sterilization on the stability of phospholipid-stabilized submicron emulsions. Acta Pharm. Nord. 1992, 4, 51.
38. Saito, H., Kawagishi, A., Tanaka, M., Tanimoto, T. et al., Coalescence of lipid emulsions in floating and freeze-thawing processes: Examination of the coalescence transition state theory. J. Colloid Interfaces SCI 1999, 219, 129-134.
39. Ghosh, S., Coupland, J. N., Factors affecting the freeze-thaw stability of emulsions. Food Hydrocolloid 2008, 22, 105-111.
40. Thanasukarn, P., Pongsawatmanit, R., McClements, D., Influence of emulsifier type on freeze-thaw stability of hydrogenated palm oil-in-water emulsions. Food Hydrocolloid 2004, 18, 1033-1043.